Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Loxapine
Drug ID BADD_D01326
Description An antipsychotic agent used in schizophrenia. [PubChem]
Indications and Usage For the management of the manifestations of psychotic disorders such as schizophrenia
Marketing Status Prescription; Discontinued
ATC Code N05AH01
DrugBank ID DB00408
KEGG ID D02340
MeSH ID D008152
PubChem ID 3964
TTD Drug ID D0U5OE
NDC Product Code 0527-1395; 64850-891; 70518-1896; 0527-1397; 35573-438; 0591-0371; 70518-0346; 70518-2120; 0527-1396; 35573-437; 0527-1394; 64850-893; 0591-0372; 0591-0369; 70518-0416; 35573-436; 0591-0370; 64850-890; 64850-892; 70518-1681; 53296-0095; 50090-4701; 70518-0283; 35573-439; 70518-0347
Synonyms Loxapine | 2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine | Oxilapine | Cloxazepine | Loxapine Hydrochloride | Hydrochloride, Loxapine | Loxitane | Loxapine Succinate | Succinate, Loxapine | Loxapinsuccinate | Loxipine Succinate | Loxipine Maleate | Maleate, Loxipine | CL-71,563 | CL 71,563 | CL71,563 | Loxapine Monohydrochloride
Chemical Information
Molecular Formula C18H18ClN3O
CAS Registry Number 1977-10-2
SMILES CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Orthostatic hypotension24.06.03.004; 17.05.01.020--Not Available
Paraesthesia17.02.06.005--
Photosensitivity reaction23.03.09.003--
Polydipsia14.05.02.001; 05.03.03.002--Not Available
Protrusion tongue17.02.05.037; 07.14.02.002--Not Available
Pruritus23.03.12.001--
Rash23.03.13.001--Not Available
Renal failure20.01.03.005--Not Available
Respiratory depression22.02.01.010; 17.02.05.047--Not Available
Salivary hypersecretion07.06.01.009--Not Available
Seborrhoea23.02.07.001--Not Available
Seborrhoeic dermatitis23.03.04.018--Not Available
Seizure17.12.03.001--
Sensory loss17.02.07.007--Not Available
Shock24.06.02.002--Not Available
Somnolence19.02.05.003; 17.02.04.006--
Syncope24.06.02.012; 17.02.04.008; 02.01.02.008--
Tachycardia02.03.02.007--Not Available
Tardive dyskinesia17.01.02.012--Not Available
Tension19.06.02.005--Not Available
Throat irritation22.02.05.013; 07.05.03.004--Not Available
Throat tightness22.02.05.015; 19.01.02.005--Not Available
Thrombocytopenia01.08.01.002--Not Available
Tremor17.01.06.002--
Urinary retention20.02.02.011--
Vision blurred06.02.06.007; 17.17.01.010--
Vomiting07.01.07.003--
Weight decreased13.15.01.005--
Weight increased13.15.01.006--
Wheezing22.03.01.009--
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages